TNTeymur NooriMScSlidesetHIVViral Hepatitis and Liver DiseaseCOVID-19Central and Eastern European Meeting on Viral Hepatitis and HIV 2021Rollout of PrEP in Europe: Success Stories and Challenges - Teymur Noori, MScView Slideset
MMMila MaistatSlidesetHIVViral Hepatitis and Liver DiseaseCOVID-19Central and Eastern European Meeting on Viral Hepatitis and HIV 2021Update on the Use of Generic Drugs for HIV in Europe - Liudmyla MaistatView Slideset
MMMojca MatičičMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseCOVID-19Central and Eastern European Meeting on Viral Hepatitis and HIV 2021EASL Guidelines on Viral Hepatitis Elimination - Mojca Matičič, MD, PhDView Slideset
TTTengiz TsertsvadzeMD, PHDSlidesetHIVViral Hepatitis and Liver DiseaseCOVID-19Central and Eastern European Meeting on Viral Hepatitis and HIV 2021The Georgian Model for Hepatitis C Elimination (With Reflection on the Impact of COVID-19 Pandemic) - Tengiz Tsertsvadze, MD, PHDView Slideset
NSNicole SeguyMD, MPHSlidesetHIVViral Hepatitis and Liver DiseaseCOVID-19Central and Eastern European Meeting on Viral Hepatitis and HIV 2021A Report on The Progress Towards Ending HIV - Nicole Seguy, MD, MPHView Slideset
JKJustyna KowalskaMD, PhDSlidesetHIVCOVID-19RSVLiverpool Course 2021Liverpool Course 2021 - Dr. Justyna Kowalska - Case 3: The Challenge of the Patient with HIV and COVID-19View Slideset
DCDario CattaneoPharmD, PhDSlidesetHIVRSVLiverpool Course 2021Liverpool Course 2021 - Dr. Dario Cattaneo - Case 2: The Patient with Multiple Comorbidities. The Case for De-PrescribingView Slideset
SKSaye KhooMD, PhDSlidesetHIVRSVLiverpool Course 2021Liverpool Course 2021 - Dr. Saye Khoo - Case 1: ARV Absorption in a Patient Undergoing Bowel SurgeryView Slideset
MBMarta BoffitoMD, PhD, FRCP, MBASlidesetHIVRSVLiverpool Course 2021Liverpool Course 2021 - Dr. Marta Boffito - Clinical Pharmacology of Long-Acting Therapy: Focus on Understudied PopulationsView Slideset
GDPGiovanni Di PerriMD, PhDSlidesetHIVRSVLiverpool Course 2021Liverpool Course 2021 - Dr. Giovanni Di Perri - Clinical Pharmacology of 2 Drug RegimensView Slideset
SlidesetTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016Pharmacokinetic Modeling and Simulation of the Interaction between Moxifloxacin and Rifapentine in Healthy Volunteers | M. ImperialView Slideset
SlidesetTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016Rifampin vs. Rifapentine: a debate over the preferred rifamycin | Kelly Dooley, MD, PhDView Slideset
